Xilio Therapeutics's total assets for Q2 2025 were $133.81M, an increase of 29.02% from the previous quarter. XLO total liabilities were $126.74M for the fiscal quarter, a 36.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.